Ms. Large joined Trillium in 2019 and has more than 20 years of leadership in the strategy, design and execution of global clinical programs, from phase 1 through phase 3. Her clinical development and operations experience has been focused in oncology and spans academic, CRO, pharma and biotech roles. Kathleen most recently served at Aileron as VP of Development Operations, where she was responsible for the planning and execution of all clinical trials. She held similar roles at Epizyme and Histogenics, and, prior to her biotech experiences, at Millennium, Eli Lilly, Quintiles, and University Hospitals of Cleveland. Kathleen holds a Master of Science in Nursing from the University of California at San Francisco and a Bachelor of Science in Nursing from Boston College.